FDA (Drugs) recall action 70452
The FDA (Drugs) publishes a recall like this one as 470 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 470 pages.
Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Penicillin Cross Contamination: All lots of all products repackaged between 01/05/12 through 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Stability Data Does Not Support Expiry: All lots of all products repackaged and distributed between 01/05/12 through 02/12/15 are being recalled because they were repackaged without data to support the printed expiry date.
The agency’s own wording, quoted from the enforcement report.
The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.
Attix Pharmaceuticals is recalling Linezolid active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Attix Pharmaceuticals is recalling Methylprednisolone Acetate active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Attix Pharmaceuticals is recalling Mirtazapine active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Attix Pharmaceuticals is recalling Histamine Phosphate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Attix Pharmaceuticals is recalling all lots of Potassium Chloride active pharmaceutical ingredient distributed between January 5, 2012, and February 12, 2015, due to potential penicillin cross-contamination.
Attix Pharmaceuticals is recalling all lots of hydrocortisone base active pharmaceutical ingredient distributed between January 5, 2012, and February 12, 2015, due to potential penicillin cross-contamination.
Attix Pharmaceuticals is recalling Dextran-70 active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Attix Pharmaceuticals is recalling 5-Fluorouracil active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Attix Pharmaceuticals is recalling cisplatin active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Attix Pharmaceuticals is recalling Prednisolone Anhydrous Micronized API due to potential penicillin cross-contamination from inadequate facility separation.
Attix Pharmaceuticals is recalling Prednisolone Anhydrous active pharmaceutical ingredient due to potential penicillin cross contamination during repackaging.
Attix Pharmaceuticals is recalling Hydroxyzine HCl active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Attix Pharmaceuticals is recalling Omeprazole Sodium active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Attix Pharmaceuticals is recalling Pregelatinized Starch pharmaceutical ingredients due to potential penicillin cross-contamination from inadequate facility separation.
Attix Pharmaceuticals is recalling Lomustine active pharmaceutical ingredient distributed to compounding pharmacies and research organizations due to potential penicillin cross-contamination.
Attix Pharmaceuticals is recalling Levomefolate Calcium API due to potential penicillin cross-contamination from inadequate facility separation. The recall affects lots distributed nationwide to compounding pharmacies and research organizations.
Attix Pharmaceuticals is recalling Metronidazole Benzoate active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Attix Pharmaceuticals is recalling Leucovorin Calcium active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Attix Pharmaceuticals is recalling Zidovudine active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Attix Pharmaceuticals is recalling zolmitriptan active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Attix Pharmaceuticals is recalling Hydroxocobalamin HCl active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Attix Pharmaceuticals is recalling Labetalol HCl active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Attix Pharmaceuticals is recalling Thimerosal active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Attix Pharmaceuticals is recalling Fluconazole active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Attix Pharmaceuticals is recalling Vancomycin HCl active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.